MMRGlobal Shareholder Update on Walgreens Litigation

MMRGlobal Shareholder Update on Walgreens Litigation 
LOS ANGELES, CA -- (Marketwired) -- 12/02/13 --  MyMedicalRecords,
Inc., through its wholly owned subsidiary, MMRGlobal, Inc. (OTCQB:
MMRF) (collectively, "MMR"), today announced that Walgreen Co. filed
a Joint Stipulation requesting additional time to respond to a motion
brought by MyMedicalRecords. The November 26, 2013 filing states,
amongst other things, that during the week of November 11, 2013 and
prior to filing MMR's motion, the parties engaged in various
telephone conversations regarding a resolution to MMR's patent
infringement case against Walgreen Co. filed in the United States
District Court, Central District Case No.: CV13-00631-ODW (SHx).
Ultimately the parties agreed to an in-person meeting at Walgreen Co.
in Deerfield, IL on Tuesday, November 19, which meeting did occur. 
The parties continued to exchange e-mails regarding a resolution to
the litigation after the November 19th in-person meeting and continue
to discuss a resolution of the matter notwithstanding the pending
As set forth in the stipulation, another follow-up meeting is
currently scheduled for December 3, 2013. The parties desire to focus
on a potential resolution over the next week and a half instead of
incurring costs and attorneys' fees associated with this matter. 
Based upon the joint resolution, the court granted the stipulation. 
About MMRGlobal
 MMRGlobal, Inc., through its wholly-owned operating
subsidiary, MyMedicalRecords, Inc., provides secure and easy-to-use
online Personal Health Records ("PHRs") and electronic safe deposit
box storage solutions, serving consumers, healthcare professionals,
employers, insurance companies, financial institutions, retail
pharmacies, and professional organizations and affinity groups. The
MyMedicalRecords PHR enables individuals and families to access their
medical records and other important documents, such as birth
certificates, passports, insurance policies and wills, anytime from
anywhere using the Internet. MyMedicalRecords is built on
proprietary, patented technologies to allow documents, images and
voicemail messages to be transmitted and stored in the system using a
variety of methods, including fax, phone, or file upload without
relying on any specific electronic medical record platform to
populate a user's account. The Company's professional offering,
MMRPro, is designed to give physicians' offices an easy and
cost-effective solution to digitizing paper-based medical records and
sharing them with patients through an integrated patient portal.
Through its merger with Favrille, Inc. in January 2009, the Company
acquired intellectual property biotech assets that include anti-CD20
antibodies and data and samples from its FavId(TM)/Specifid(TM)
vaccine clinical trials for the treatment of B-Cell Non-Hodgkin's
lymphoma. To learn more about MMRGlobal, Inc. visit View demos and video tutorials of the Company's
products and services at 
Forward-Looking Statements 
 All statements in this press release
that are not strictly historical in nature, including, without
limitation, intellectual property enforcement actions, infringement
claims or litigation, intellectual property licenses, and future
performance, management's expectations, beliefs, intentions,
estimates or projections, constitute "forward-looking statements."
Such forward-looking statements involve known and unknown risks,
uncertainties and other factors that may cause MMR's actual results
to be materially different from historical results or from any
results expressed or implied by such forward-looking statements. Some
can be identified by the use of words (and their derivations) such as
"need," "possibility," "potential," "intend," "offer," "development,"
"if," "negotiate," "when," "begun," "believe," "achieve," "will,"
"estimate," "expect," "maintain," "plan," and "continue," or the
negative of these words. Actual outcomes and results of operations
and the timing of selected events may differ materially from the
results predicted, and any reported results should not be considered
as an indication of future performance. Such statements are
necessarily based on assumptions and estimates and are subject to
various risks and uncertainties, including those relating to the
possible invalidity of the underlying assumptions and estimates and
possible changes or developments in economic, business, industry,
market, legal and regulatory circumstances and conditions and actions
taken or omitted to be taken by third parties, including customers,
suppliers, business partners, potential licensees, competitors and
legislative, judicial and other governmental authorities and
officials. Factors that could cause or contribute to such differences
include, but are not limited to: unexpected outcomes with respect to
intellectual property enforcement actions, claims of intellectual
property infringement and general intellectual property litigation;
our ability to maintain, develop, monetize and protect our patent
portfolio for both MMR's health IT and biotechnology intellectual
property assets in the U.S. and internationally; the timing of
milestone payments in connection with licensing our intellectual
property; our ability to establish and maintain strategic
relationships; changes in our relationships with our licensees; the
risk MMR's products are not adopted or viewed favorably by the
healthcare community and consumer retail market; business prospects,
results of operations or financial condition; risks related to the
current uncertainty and instability in financial and lending markets,
including global economic uncertainties; the timing and volume of
sales and installations; the length of sales cycles and the
installation process; the market's acceptance of new product and
service introductions; competitive product offerings and promotions;
changes in government laws and regulations including the 2009 HITECH
Act and changes in Meaningful Use and the 2010 Affordable Care Act;
future changes in tax legislation and initiatives in the healthcare
industry; undetected errors in our products; the possibility of
interruption at our data centers; risks related to third party
vendors; risks related to obtaining and integrating third-party
licensed technology; risks related to a security breach by third
parties; risks associated with recruitment and retention of key
personnel; other litigation matters; uncertainties associated with
doing business internationally across borders and territories; and
additional risks discussed in MMR's filings with the Securities and
Exchange Commission. MMR is providing this information as of the date
of this release and, except as required by applicable law, does not
undertake any obligation to update any forward-looking statements
contained in this release as a result of new information, future
events or otherwise.  
Michael Selsman
Public Communications Co.
(310) 922-7033 
Press spacebar to pause and continue. Press esc to stop.